Tsai Ming-Horng, Hsu Jen-Fu, Chu Shih-Ming, Lien Reyin, Huang Hsuan-Rong, Chiang Ming-Chou, Fu Ren-Huei, Lee Chiang-Wen, Huang Yhu-Chering
From the *Department of Pediatrics, Division of Neonatology and Pediatric Hematology/Oncology, Chang Gung Memorial Hospital, Yunlin; †College of Medicine, Chang Gung University, Taoyuan; ‡Chang Gung University of Science and Technology, Chiayi; §Department of Pediatrics, Division of Pediatric Neonatology; and ¶Department of Pediatrics, Division of Pediatric Infectious Disease, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Pediatr Infect Dis J. 2014 Jan;33(1):e7-e13. doi: 10.1097/INF.0b013e3182a72ee0.
Late-onset sepsis (LOS) is a common complication in the neonatal intensive care unit. We aimed to describe the epidemiology, clinical characteristics and risk factors for adverse outcome in neonates with LOS.
We conducted a cohort study of all neonates with LOS at the neonatal intensive care unit of a Tertiary Taiwan Medical Center from January 2004 through December 2011 and used multivariate logistic regression to identify risk factors for final adverse outcome.
Among 5010 neonates over 253,644 neonate-days, 713 (14.2%) experienced a total of 942 episodes of LOS (incidence rate, 3.71 episodes per 1000 neonate-days). Although the rates of LOS were inversely proportional to birth weight and gestational age, the incidence rates were comparable among extremely preterm, late preterm and full term neonates. Fungemia was found to have significantly higher rate of infectious complication (30.8%), persistent bloodstream infection (19.2%) and sepsis attributable mortality (23.1%). The overall mortality rate was 12.6% (90/713), and sepsis attributable mortality rate was 7.2% (68/942 episodes). Independent predictors of in-hospital mortality were Pseudomonas LOS (adjusted odds ratio [OR], 14.31; 95% confidence interval [CI]: 3.87-53.0), fungemia (OR, 5.69; 95% CI: 2.48-13.01), presence of congenital anomalies (OR, 4.12; 95% CI: 1.60-10.60), neuromuscular comorbidities (OR, 3.34; 95% CI: 1.66-6.73) and secondary pulmonary hypertension with/without cor pulmonale (OR, 23.48; 95% CI: 5.96-92.49).
LOS predisposes hospitalized neonates to increased risk of mortality or morbidity, especially caused by Pseudomonas aeruginosa or Candida spp. More aggressive treatment strategy is worth consideration in neonates with presumed LOS, particularly those with certain underlying chronic conditions.
迟发性败血症(LOS)是新生儿重症监护病房常见的并发症。我们旨在描述LOS新生儿的流行病学、临床特征及不良结局的危险因素。
我们对2004年1月至2011年12月期间台湾某三级医疗中心新生儿重症监护病房的所有LOS新生儿进行了一项队列研究,并使用多因素逻辑回归分析来确定最终不良结局的危险因素。
在253,644个新生儿日中的5010例新生儿中,713例(14.2%)共发生942次LOS发作(发病率为每1000个新生儿日3.71次发作)。虽然LOS发生率与出生体重和胎龄成反比,但极早产儿、晚期早产儿和足月儿的发病率相当。发现真菌血症的感染并发症发生率(30.8%)、持续性血流感染发生率(19.2%)和败血症归因死亡率(23.1%)显著更高。总体死亡率为12.6%(90/713),败血症归因死亡率为7.2%(68/942次发作)。院内死亡的独立预测因素为铜绿假单胞菌LOS(调整后的优势比[OR],14.31;95%置信区间[CI]:3.87 - 53.0)、真菌血症(OR,5.69;95%CI:2.48 - 13.01)、先天性异常的存在(OR,4.12;95%CI:1.60 - 10.60)、神经肌肉合并症(OR,3.34;95%CI:1.66 - 6.73)以及伴/不伴肺心病的继发性肺动脉高压(OR,23.48;95%CI:5.96 - 92.49)。
LOS使住院新生儿面临更高的死亡或发病风险,尤其是由铜绿假单胞菌或念珠菌属引起的。对于疑似LOS的新生儿,尤其是那些患有某些潜在慢性疾病的新生儿,更积极的治疗策略值得考虑。